Crawford Investment Counsel Inc Pfizer Inc Transaction History

Crawford Investment Counsel Inc

  • $5.21 Billion
  • Q2 2024

A detailed history of Crawford Investment Counsel Inc transactions in Pfizer Inc stock. As of the latest transaction made, Crawford Investment Counsel Inc holds 1,817,924 shares of PFE stock, worth $52.9 Million. This represents 0.98% of its overall portfolio holdings.

Number of Shares
1,817,924
Previous 1,777,339 2.28%
Holding current value
$52.9 Million
Previous $49.3 Million 3.13%
% of portfolio
0.98%
Previous 0.92%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$25.26 - $29.6 $1.03 Million - $1.2 Million
40,585 Added 2.28%
1,817,924 $50.9 Million
Q1 2024

May 15, 2024
BUY
$25.89 - $29.73 $5.82 Million - $6.68 Million
224,802 Added 14.48%
1,777,339 $49.3 Million
Q4 2023

Feb 14, 2024
BUY
$26.13 - $33.94 $3.39 Million - $4.4 Million
129,770 Added 9.12%
1,552,537 $44.7 Million
Q3 2023

Nov 14, 2023
BUY
$32.09 - $37.51 $950,922 - $1.11 Million
29,633 Added 2.13%
1,422,767 $47.2 Million
Q2 2023

Aug 14, 2023
BUY
$36.12 - $41.79 $5.72 Million - $6.62 Million
158,417 Added 12.83%
1,393,134 $51.1 Million
Q1 2023

May 15, 2023
BUY
$39.39 - $51.28 $24.1 Million - $31.4 Million
612,949 Added 98.58%
1,234,717 $50.4 Million
Q4 2022

Feb 14, 2023
SELL
$41.75 - $54.5 $448,436 - $585,384
-10,741 Reduced 1.7%
621,768 $31.9 Million
Q3 2022

Nov 14, 2022
BUY
$43.76 - $53.42 $774,333 - $945,266
17,695 Added 2.88%
632,509 $27.7 Million
Q2 2022

Aug 15, 2022
BUY
$46.53 - $55.17 $257,124 - $304,869
5,526 Added 0.91%
614,814 $32.2 Million
Q1 2022

May 16, 2022
SELL
$45.75 - $56.69 $1.77 Million - $2.19 Million
-38,691 Reduced 5.97%
609,288 $31.5 Million
Q4 2021

Feb 07, 2022
SELL
$41.32 - $61.25 $1.26 Million - $1.87 Million
-30,546 Reduced 4.5%
647,979 $38.3 Million
Q3 2021

Nov 15, 2021
SELL
$39.25 - $50.42 $1.86 Million - $2.38 Million
-47,297 Reduced 6.52%
678,525 $29.2 Million
Q2 2021

Aug 16, 2021
BUY
$35.91 - $40.68 $923,282 - $1.05 Million
25,711 Added 3.67%
725,822 $28.4 Million
Q1 2021

May 14, 2021
BUY
$33.49 - $37.77 $1.65 Million - $1.86 Million
49,174 Added 7.55%
700,111 $25.4 Million
Q4 2020

Feb 01, 2021
BUY
$33.47 - $42.56 $2.05 Million - $2.6 Million
61,165 Added 10.37%
650,937 $24 Million
Q3 2020

Oct 29, 2020
BUY
$31.75 - $37.25 $2.09 Million - $2.45 Million
65,698 Added 12.54%
589,772 $21.6 Million
Q2 2020

Aug 13, 2020
BUY
$30.12 - $36.54 $2.23 Million - $2.71 Million
74,144 Added 16.48%
524,074 $17.1 Million
Q1 2020

May 15, 2020
BUY
$27.03 - $38.62 $9.21 Million - $13.2 Million
340,748 Added 312.09%
449,930 $14.7 Million
Q4 2019

Feb 14, 2020
SELL
$32.92 - $37.36 $129,606 - $147,086
-3,937 Reduced 3.48%
109,182 $4.28 Million
Q3 2019

Nov 12, 2019
SELL
$32.49 - $42.13 $364,635 - $472,824
-11,223 Reduced 9.03%
113,119 $4.06 Million
Q2 2019

Aug 12, 2019
SELL
$36.98 - $41.52 $375,716 - $421,843
-10,160 Reduced 7.55%
124,342 $5.39 Million
Q1 2019

May 09, 2019
SELL
$37.5 - $41.2 $1.97 Million - $2.17 Million
-52,610 Reduced 28.12%
134,502 $5.71 Million
Q4 2018

Feb 14, 2019
SELL
$38.47 - $43.86 $8.8 Million - $10 Million
-228,662 Reduced 55.0%
187,112 $8.17 Million
Q3 2018

Nov 09, 2018
SELL
$34.47 - $41.81 $530,941 - $643,999
-15,403 Reduced 3.57%
415,774 $18.3 Million
Q2 2018

Aug 14, 2018
SELL
$32.98 - $35.16 $702,869 - $749,329
-21,312 Reduced 4.71%
431,177 $15.6 Million
Q1 2018

May 15, 2018
SELL
$31.91 - $37.02 $94,134 - $109,209
-2,950 Reduced 0.65%
452,489 $16.1 Million
Q4 2017

Feb 13, 2018
SELL
$33.26 - $35.29 $32,195 - $34,160
-968 Reduced 0.21%
455,439 $16.5 Million
Q3 2017

Nov 14, 2017
BUY
$31.0 - $34.15 $14.1 Million - $15.6 Million
456,407
456,407 $16.3 Million

Others Institutions Holding PFE

# of Institutions
3,220
Shares Held
3.71B
Call Options Held
73.2M
Put Options Held
108M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $163B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Crawford Investment Counsel Inc Portfolio

Follow Crawford Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crawford Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Crawford Investment Counsel Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email